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Background: A complex of MCM proteins is implicated
in ensuring that DNA replicates only once in each cell
cycle, by 'replication licensing'. The nuclear membrane is
also implicated in replication licensing, but the relation-
ship between the MCM proteins and the nuclear mem-
brane is unclear. Here, we investigate the relationship
between XMCM3 (a component of the Xenopus MCM
complex), nuclear envelope permeability and the
initiation of DNA replication once per cell cycle.
Results: Our results show that the nuclear envelope does
not prevent the entry of XMCM3 into the nucleus, but
that it does prevent the binding of XMCM3 to chromatin.
We have also identified another component of the Xeno-
pus MCM complex as a homologue of the Schizosaccharo-
myces pombe protein Cdc21. XMCM3 does not prefer-
entially co-localize with sites of DNA replication. Instead,
it is almost uniformly distributed on chromatin and is
suddenly lost during replication. XMCM3 crosses intact
nuclear membranes of G2-phase HeLa cells but cannot
then bind to chromatin. Permeabilization of the nuclear
envelope allows the binding of XMCM3 to G2-phase
chromatin. We have therefore resolved replication licens-
ing into two stages. The first requires the entry of a
cytosolic 'loading factor' that is excluded by the nuclear
membrane; subsequently, MCM3 can bind to chromatin
in the presence or absence of a nuclear membrane, but
only if the loading factor has gained access in the absence
of the membrane.
Conclusions: The Xenopus MCM complex contains
homologues of yeast MCM2, MCM3, MCM5 and
Cdc21 proteins. XMCM3 is displaced from chromatin
during replication. The nuclear envelope allows entry of
XMCM3 into the nucleus, but regulates its binding to
chromatin; binding requires a loading factor which can-
not cross the nuclear envelope. Based on these results, we
present a two-stage model for replication licensing.
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Background
In eukaryotic cells, DNA replication is regulated so that
the genome is replicated once and only once per cell
cycle; reinitiation of replication does not occur until the
next cell cycle. Early cell fusion experiments demon-
strated a clear difference between pre-replicative (G1
phase) and post-replicative (G2 phase) nuclei. When G1-
or G2-phase cells are fused with S-phase cells, the G1
nucleus can replicate its DNA but the G2 nucleus repli-
cates only after the hybrid cell has passed through mitosis
[1]. Experiments in vitro using a cell-free system derived
from Xenopus egg extracts show that nuclear membrane
breakdown is the only feature of mitosis required for re-
replication to be permitted [2]. It has been suggested that
the nuclear membrane might prevent access to chromatin
of a hypothetical licensing factor that is essential for the
initiation of replication. This factor would gain access to
chromatin only during mitotic nuclear membrane break-
down, and would be inactivated during S-phase. The in-
tegrity of the nuclear membrane would then prevent fur-
ther rounds of replication taking place until after mitosis
[2]. Evidence for the existence of at least one positive
factor that behaves in this way has been presented [3-5].
Although licensing factor has yet to be described in
molecular terms, genetic screens in budding yeast have
been helpful in identifying candidate molecules. The
MCM2, MCM3 and MCM5 genes were originally iso-
lated because mutations in them affect the ability of yeast
cells to retain minichromosomes during successive cell
cycles [6]. The minichromosome maintainance defect is
specific to individual autonomously replicating sequences
(ARSs), indicating possible interactions of the MCM pro-
teins with replication origins [6,7]. MCMs 2, 3 and 5 are
highly homologous to each other, and define a family of
proteins involved in replication [8]. Homologues of each
family member are found in higher organisms, as well as
in fission yeast [8-12]. Screens for mutants defective in the
cell cycle have identified other members of the MCM
family, such as Cdc21 [13], CDC47 [14] and CDC46
[15], which was later shown to be identical to MCM5
[16]. MCM2, MCM3 and MCM5/CDC46 are found in
the nucleus during mitosis, persist in the nucleus during
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G1 phase, and disappear from the nucleus at the begin-
ning of S phase [15,17]. These three proteins therefore
satisfy two of the attributes of licensing factor: involve-
ment in DNA replication and cell-cycle dependent
nuclear localization.
The requirement for the MCM family members in yeast
DNA replication is consistent with the observation that
S phase is disrupted by the microinjection of anti-
MCM2 or anti-MCM3 antibodies into cultured mam-
malian cells [11,18]. However, immunolocalization
studies of MCM homologues in higher organisms show
that the proteins are exclusively nuclear throughout the
cell cycle ([10,11,18,19]; T. Krude, C. Musahl, R.A.L.
and R. Knippers, personal communication).
A Xenopus homologue of yeast MCM3 (XMCM3) has
been cloned and shown to be involved in licensing DNA
for replication [20-22]. XMCM3 binds to G-phase
chromatin, is displaced during replication and is absent
from G2-phase chromatin [20-22]. Consistent with these
observations, murine MCM3 and human MCM2,
MCM3, CDC46 and CDC21 homologues are also
displaced from chromatin during S phase ([18,23]; T.
Krude, C. Musahl, R.A.L. and R. Knippers, personal
communication). The binding of XMCM3 to chromatin
is essential for the initiation of DNA replication [20-22].
Immunodepletion of Xenopus egg extracts using anti-
XMCM3 antibodies removes a complex consisting of
XMCM3 and presumed Xenopus homologues of MCM2
and MCM5/CDC46. This complex is not required for
replication of permeabilized HeLa G-phase nuclei.
However, permeabilized HeLa G2-phase nuclei are
unable to replicate in an extract depleted of the 'MCM
complex' [20]. This complex is therefore involved in
distinguishing between the G1 and G2 states.
We have also shown, however, that the MCM complex
does not fulfil one of the criteria for licensing factor, in
that it can cross an intact nuclear envelope and bind to
G1-phase chromatin [20]. So, why is permeabilization of
the nuclear membrane required for a replicated nucleus
to replicate again? We address this question here by
looking at the regulation of binding of XMCM3 to
chromatin. In addition, we examine the distribution of
chromatin-bound XMCM3, and ask whether its loss
from chromatin is dependent on replication.
Results
Sequence analysis of XMCM3
We have previously- described the cloning of XMCM3
[20]. The 2.6 kbp XMCM3 cDNA sequence is highly
homologous to that of other MCM family members at
both the nucleotide and predicted amino-acid levels (Fig.
1), a conclusion that was corroborated by Kubota et al.
[22]. The sequence contains an open reading frame of
2423 bp, encoding a protein of predicted molecular mass
90.4 kDa. The apparent discrepancy between this figure
and the mass determined by SDS-PAGE (104 kDa) may
be due to the high proportion of charged residues
(34.8 %; pI 6.85) in the sequence. Unlike yeast MCM2
[24], and in common with the other MCM3 homo-
logues that have been identified so far, XMCM3 does
not appear to have a zinc-finger motif, or indeed any
other obvious DNA-binding domain.
Of the several regions rich in basic residues that are found
in XMCM3, which may potentially serve as nuclear
localization sequences (NLSs), none bears obvious simi-
larity to the simian virus 40 (SV40) large T antigen NLS
or to bipartite NLSs [25]. Other members of the complex
may be responsible for providing a functional NLS.
Kimura et al. [18] have shown that the human MCM3
protein is phosphorylated during DNA replication. A
MOTIFs search [26] shows that there are 10 potential
phosphorylation sites for DNA-dependent protein kinase
[27] within the sequence of XMCM3 (Fig. 1). Strikingly,
with the exception of a site at position 352, all of the
sites are clustered in the final quarter of the protein.
Figure 1 also shows other potential phosphorylation sites.
The three S/T-P pairs (single-letter amino-acid code)
within the sequence do not match the optimal consensus
sequence (K/R-S/T-P-X-K/R) for phosphorylation by
complexes made up of a cyclin and a cyclin-dependent
kinase [28].
Fig. 1 Comparison of Xenopus MCM3
with other members of the MCM family
of proteins. Homology boxes I, II and III
are shown as shaded areas in the coding
region of XMCM3. An amino-acid
sequence alignment (single-letter code)
of selected members of the MCM family
(human P1 (MCM3) [19]; S. cerevisiae
MCM3 [24]; human BM28 (MCM2)
[11]; S. cerevisiae CDC46 115]; S.
pombe Cdc21 [13]), centered on the
MCM family signature sequence,
IDEFDKM [43], is shown above. Con-
sensus sites for phosphorylation by pro-
tein kinase C, DNA-dependent protein
kinase, cAMP/cGMP-dependent protein
kinase and casein kinase II are indicated.
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Fig. 2. Identification of a CDC21
homologue as an additional member of
the Xenopus MCM complex. (a) Three
anti-XMCM3 antibodies (Abs 2, 3 and
4; [20]) immunoprecipitate the same
five proteins from Xenopus egg extracts.
(b) Anti-XMCM3 immunoprecipitates
contain a protein that reacts with anti-
bodies directed against human CDC21
[291. Three of the remaining proteins
have previously been identified as
homologues of MCMs 2, 3 and 5 [20].
All five proteins are recognized by an
antibody directed against a conserved
domain present throughout the MCM2/3/5 protein family [9] (a gift from R. Burkhart). The two right-hand lanes show that
two sequential immunoprecipitations with anti-XMCM3 antibodies completely remove XMCM3 from extracts.
CDC21 is an additional component of the MCM complex
In an earlier publication [20], we described XMCM3 as a
component of a complex of at least four proteins in
Xenopus egg extracts. We identified two other members
of the complex as homologues of Saccharomyces cerevisiae
MCM2 and MCM5 proteins [20].
When the MCM3 complex from Xenopus egg extracts
was immunoprecipitated and run further than previously
on a 5 % polyacrylamide gel, another protein was clearly
resolved (Fig. 2a). Western immunoblot analysis allowed
us to identify this new protein as the Xenopus homologue
of human CDC21 [29] (which is itself a homologue of
Schizosaccharomyces pombe Cdc21 [13]) (Fig. 2b). Further-
more, immunoblots of mock immunoprecipitations
probed with anti-human-CDC21 antibodies did not give
a signal (data not shown), implying that this antibody
recognizes a protein that is specific to the complex. This
protein also cross-reacts with an antibody raised against
the central conserved region of the MCM family of pro-
teins [9]. Three of the four remaining bands correspond
to proteins that we have previously identified as
homologues of MCMs 2, 3 and 5. The anti-XMCM3
antibodies react specifically only with XMCM3 on
immunoblots (Fig. 2b; [20]), suggesting that the Xenopus
homologues of MCM2, MCM5 and CDC21 are present
in a complex with XMCM3 in egg extracts and are not
cross-reacting antigens.
Binding of XMCM3 to chromatin during replication
Previously, murine, human and Xenopus MCM3 proteins
have been shown to bind to chromatin before the initia-
tion of DNA replication, and to become displaced dur-
ing replication ([18,20-22]; T. Krude, C. Musahl, R.A.L.
and R. Knippers, personal communication). Interest-
ingly, XMCM3 binds to sperm chromatin before the
formation of the nuclear membrane and before replica-
tion protein A (RPA) binds and forms pre-replication
initiation complexes [22].
We have used confocal microscopy to monitor the
sub-nuclear localization of XMCM3 before and during
replication. Figure 3a confirms that the binding of
XMCM3 to Xenopus sperm chromatin precedes the
formation of an intact nuclear envelope; it also shows
that the staining pattern is neither homogeneous nor dis-
cretely punctate. In contrast, DNA staining with Hoechst
33258 was homogeneous within nuclei at all time points
(data not shown). As replication proceeded, there was a
rapid decrease in XMCM3 nuclear immunofluorescence
(Fig. 3b,c; green). The same results were obtained when
nuclei were washed in a detergent-containing buffer
before fixation to select for tightly bound XMCM3 (data
not shown).
As XMCM3 is essential for DNA replication [20-22], we
determined whether the chromatin-bound protein co-
localized to sites of replication in Xenopus sperm nuclei.
Nuclei were harvested at a time when DNA synthesis
was first visible, as detected by biotin-dUTP incorpora-
tion (Fig. 3b). The results show that these sites of replica-
tion initiation (red in Fig. 3) do not preferentially
co-localize with XMCM3 (green in Fig. 3). Co-localiza-
tion would result in the appearance of yellow merged
images, as for the co-localization of RPA with sites of
replication initiation (Fig. 3d; [30]). Surprisingly,
XMCM3 did not co-localize with sites of initiation or
elongation. Instead, XMCM3 immunofluorescence was
preferentially excluded from replicated DNA throughout
S phase (Fig. 3b,c and data not shown).
XMCM3 immunofluorescence decreases suddenly during
replication
It has been demonstrated previously that the loss of
chromatin-bound XMCM3 from a population of nuclei
during replication is gradual [20,21]. Apparently, the pro-
portion of XMCM3 that is bound to chromatin directly
correlates with the amount of unreplicated DNA [21].
However, these experiments present only an average
from a population of nuclei, and give no information on
the level of XMCM3 in individual nuclei during replica-
tion. Here, we have used immunofluorescence to moni-
tor the amount of XMCM3 bound to chromatin in
individual nuclei. Our results show a clear difference
from those previously reported. Consistent with the data
shown in Figure 3 and previous results [20,21], XMCM3
is bound to chromatin before initiation and is lost by
60 minutes (Fig. 4b). However, in contrast to previous
results, we found that the loss of XMCM3 from chro-
matin was not gradual. Instead, XMCM3 remained
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Fig. 3. XMCM3 is almost uniformly
distributed on Xenopus sperm chromatin
(a) and is displaced as replication pro-
ceeds (b,c). Chromatin-bound XMCM3
does not co-localize preferentially with
sites of replication (b). In contrast, RPA
co-localizes with sites of replication ini-
tiation (d). In (a-d), Xenopus sperm
chromatin was incubated in egg extract
and harvested at various times: (a)
10 min; (b,d) 25 min; (c) 55 min. In (a),
(b) and (d), biotin-dUTP was added at
0 min. In (c), biotin-dUTP was added
1 min before harvesting nuclei. Samples
were stained by fluorescence confocal
microscopy, as described in Materials
and methods. Left panels (green) show
antigen distribution: XMCM3 (a-c) or
RPA (d). Centre panels (red) show
biotin-dUTP incorporation. Right panels
show merged images.
bound at high levels for at least another 10 minutes (Fig.
4b). During this time sperm chromatin continued to
replicate efficiently (Fig. 4a). This was followed by a sud-
den drop in the amount of XMCM3 bound to individual
nuclei (Fig. 4b; 40-45 minutes). This residual low level
of bound XMCM3 was gradually lost during the remain-
ing period of S phase. At 60 minutes, all nuclei had lost
XMCM3 and 96 % had completed S phase (Fig. 4a,b).
Effect of aphidicolin on chromatin-bound XMCM3
Our results illustrate that most of the XMCM3 is lost
from chromatin after a lag of 10 minutes following repli-
cation initiation. It has previously been reported that the
addition of aphidicolin, an inhibitor of DNA replication,
blocks the loss of XMCM3 from chromatin [21,22]. If
DNA replication is causing the loss of XMCM3 from
chromatin, then aphidicolin should prevent that loss.
Figure 5a shows that addition of aphidicolin at various
stages throughout S phase efficiently blocked DNA syn-
thesis in egg extract. Figure 5b shows that the addition of
aphidicolin at the start of the incubation completely pre-
vented the release of XMCM3 from chromatin. The
addition of aphidicolin at later stages blocked subsequent
release partially, but not completely. Thus, when aphidi-
colin was added at 30 minutes and the incubation contin-
ued to 60 minutes, XMCM3 immunofluorescence fell to
24 % of its peak value. In the absence of aphidicolin,
immunofluorescence would have disappeared completely
(Figs 4b,5b); alternatively, it would have remained at
100 % if the incubation was stopped at the time of aphi-
dicolin addition (compare Figs 4b,5b). When aphidicolin
was added at 40 minutes, XMCM3 immunofluorescence
completely disappeared over the next 20 minutes, from a
value of 78 % at the time of addition (Figs 4b,5b).
A detailed comparison-of Figures 4 and 5 shows that
76 % of the chromatin-bound XMCM3 immunofluores-
cence was lost when only 10% of DNA had been
replicated, but that release was delayed by a mechanism
that was not aphidicolin-sensitive. This is consistent with
initiation, rather than elongation, being the trigger for
the release of XMCM3. As the cells of Xenopus embryos
may initiate replication synchronously, it will be inter-
esting to see how this behaviour compares with that of
cultured mammalian cells, in which the delayed initiation
of replication at some sites in a nucleus has been clearly
established.
XMCM3 accumulates in intact G2-phase HeLa nuclei but is
unable to bind to chromatin
Gl-phase, but not intact G2-phase, nuclei are competent
to replicate their DNA in Xenopus egg extract [2,3,31].
We have demonstrated previously that the Xenopus MCM
protein complex is essential for DNA replication [20].
Interestingly, HeLa Gl-phase, but not HeLa G2-phase,
nuclei contain an active, chromatin-bound XMCM com-
plex [20]. However, permeabilization of the nuclear
envelope of G2-phase nuclei is sufficient to bring about
reinitiation of DNA replication in Xenopus egg extract,
provided that the XMCM complex is present [2,3,20,31].
One possible explanation for these results is that the
nuclear envelope prevents XMCM3 from entering the
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Fig. 4. XMCM3 immunofluorescence decreases suddenly during
replication. (a) Synchrony of DNA replication of Xenopus sperm
nuclei detected by 2 min pulse labelling with biotin-dUTP. (b)
XMCM3 immunofluorescence measured in individual and aver-
aged nuclei. (a,b) Xenopus sperm chromatin was incubated with
biotin-dUTP in egg extract and harvested at various times. Sam-
ples were washed with detergent-containing buffer, fixed, stained
for (a) biotin-dUTP or (b) XMCM3, and viewed by confocal
microscopy. For each time point, 10 sperm were quantified for
XMCM3 immunofluorescence (see Materials and methods) and
100 sperm were scored for biotin incorporation.
nucleus, as has been seen in yeast [8,15,17] and as would
be predicted if XMCM3 completely fulfills the role of the
licensing factor postulated by Blow and Laskey [2]. Con-
sistent with this possibility, Kubota et al. [22] reported
that an XMCM3 fusion protein was unable to cross the
nuclear envelope. In contrast, however, we found that the
native XMCM complex appeared to be able to cross an
intact nuclear envelope and to rescue DNA replication of
a nucleus that had been exposed previously to a depleted
extract [20].
To resolve this confusing situation, we tested the
hypothesis that a permeable nuclear membrane is not
required in order to allow entry of XMCM3 into the
nucleus, but is required for XMCM3 to bind to chro-
matin. We took advantage of the fact that HeLa G2-
phase nuclei do not cross-react with anti-XMCM3
antibodies, as judged by immunofluorescence (Fig. 6a).
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Fig. 5. Effect on XMCM3 immunofluorescence of inhibiting DNA
replication with aphidicolin. (a) Efficiency of inhibition of DNA
replication by aphidicolin when added at the times shown. (b)
XMCM3 fluorescence measured at 60 min, when aphidicolin was
added at the times shown. Xenopus sperm chromatin was incu-
bated with ca-[32P]dATP in egg extract. Extracts were supplemented
with aphidicolin (40 pg ml- 1) at various times. (a) In the absence of
aphidicolin, replication was complete by 60 min; the addition of
aphidicolin efficiently inhibits DNA replication. (b) Addition of
aphidicolin at 0 min completely prevents the loss of XMCM3
immunofluorescence; addition later only partly prevents the loss.
Intact HeLa G2-phase nuclei incubated in egg extract
accumulated XMCM3 but did not replicate (Fig. 6b).
This result demonstrates that the nuclear envelope does
not control DNA replication by preventing the entry of
XMCM3 into the nucleus. In contrast, permeabilized
G2-phase nuclei underwent efficient DNA replication
and accumulated XMCM3 to a greater extent (Fig. 6b).
To test whether or not XMCM3 which had crossed an
intact nuclear envelope could bind to chromatin, HeLa
G2-phase nuclei were incubated in egg extract and
washed with a detergent-containing buffer before
fixation. When nuclei with intact nuclear envelopes are
treated in this way, we observed a clear loss of immuno-
fluorescence (Fig. 6c). In contrast, when permeabilized
nuclei were treated the same way, XMCM3 remained
tightly bound to the chromatin (Fig. 6c). Similar results
were seen with replicated Xenopus sperm nuclei (data not
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Fig. 6. The nuclear envelope does not
prevent entry of XMCM3 into the
nucleus, but does regulate the binding
of XMCM3 to chromatin. Intact (top
panels) or permeabilized (lower panels)
HeLa G2-phase nuclei were: (a) stained
without incubation; (b) incubated with
biotin-dUTP in egg extract for 1 h; or (c)
treated as in (b) followed by detergent
washing. Samples were stained for DNA
(white), XMCM3 (green) and replication
(biotin-dUTP incorporation; red) and
viewed by fluorescence microscopy.
Both intact and permeabilized nuclei
accumulated XMCM3 (b), but XMCM3
could bind to the G2-phase chromatin
only in permeabilized nuclei (c).
shown). These results illustrate three critical points. First,
the nuclear envelope does not prevent nuclear entry of
XMCM3. Second, the nuclear envelope does regulate
binding of XMCM3 to chromatin. Third, initiation of
DNA replication is seen only when XMCM3 is bound
to chromatin.
We have not investigated why a bacterially expressed
XMCM3 fusion protein failed to cross the nuclear
envelope [22]. These results could be explained if there
was a protein-folding problem, or if NLS function was
disrupted by labelling with flourescein isothiocyanate. A
more interesting possibility is that a different member of
the XMCM protein complex might be responsible for
transporting the whole complex into the nucleus.
The nuclear envelope regulates the binding of XMCM3 to
chromatin via a second component
We have shown previously that unreplicated sperm nuclei
incubated in an extract from which XMCM3 has been
depleted fail to replicate. However, when they are subse-
quently transferred to an undepleted extract, XMCM3
crosses the intact nuclear envelope, binds to the chro-
matin and permits DNA replication [20]. This contrasts
with the inability of XMCM3 to bind to the chromatin
of intact HeLa G2-phase nuclei. The difference in results
could be explained if a second component is required,
and is unable to cross the nuclear envelope but is essential
for allowing XMCM3 to bind to chromatin. Exclusion
of this second component from an intact nucleus would
explain why XMCM3 is able to cross an intact nuclear
envelope but is not able to bind to replicated chromatin,
or to allow it to replicate again.
To test this possibility, we asked whether preincubation
of replicated HeLa G2-phase chromatin with extract
(depleted of the XMCM complex before repair of the
nuclear envelope) was sufficient to allow the binding of
XMCM3 to chromatin. Permeabilized G2-phase nuclei
were preincubated with an XMCM3-depleted extract; in
this extract, neither intact nor permeabilized G2-phase
nuclei could replicate (Fig. 7a,c; [20]). Following nuclear
membrane repair and transfer to mock-depleted extract,
XMCM3 was able to cross the nuclear membrane and
bind to the chromatin. Biotin-dUTP incorporation (Fig.
7b) showed that these nuclei could replicate efficiently,
and density substitution (Fig. 7c) showed that a single
round of semi-conservative replication had occurred.
These results clearly demonstrate that the control of
DNA replication is not regulated by limiting the nuclear
import of XMCM3. Intact nuclei preincubated in an
XMCM3-depleted extract and transferred to mock-
depleted extract lack chromatin-bound XMCM3 and do
not replicate (Fig. 7b,c). Figure 7c illustrates the clear dif-
ference in replication capacity between permeabilized
and intact nuclei preincubated in XMCM3-depleted
extract and transferred to mock-depleted extract. This
indicates that a second component in the egg extract
must allow XMCM3 to bind to chromatin and permit
DNA replication. The inability of intact G2-phase HeLa
nuclei to bind XMCM3 (Figs 6c,7b) suggests that this
second component cannot cross the nuclear envelope.
Discussion
Composition and location of the MCM complex in
Xenopus eggs
We have shown previously that three different polyclonal
antibodies against Xenopuis MCM3 all immunoprecipitate
a complex containing Xenopus homologues of yeast
MCMs 2, 3 and 5 [20]. All three anti-XMCM3
antibodies are monospecific on western immunoblots,
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Fig. 7. Binding of XMCM3 to chromatin
requires a second activity which cannot
cross the nuclear envelope. (a) Intact or
permeabilized HeLa G2-phase nuclei
were incubated with biotin-dUTP in
XMCM3-depleted extract -they did
not stain for XMCM3 or replicate. (b)
Following repair of the nuclear enve-
lope during incubation as in (a), nuclei
were transferred to mock-depleted egg
extract supplemented with biotin-dUTP
for 1 h and subsequently detergent-
washed. Samples were then fixed and
stained for DNA (white), XMCM3(green) and replication (red), and
viewed by fluorescence microscopy. (c)
Density substitution gradients illustrate a
clear difference in replication capacity
between permeabilized and intact HeLa
G2-phase nuclei following the proce-
dures described in (a) and (b). Extracts
before and after transfer were supple-
mented with a-[ 32P]dATP and BrdUTP.
Expected positions of heavy-heavy(HH), heavy-light (HL) and light-light
(LL) DNA are indicated. (d) Integrity of
the nuclear envelope following preincu-
bation in XMCM3-depleted extract was
monitored by exclusion of fluorescein-
labelled nucleoplasmin core fragment,
which was added immediately before
transfer and present throughout the
incubation in mock-depleted extract.
showing that precipitation is cause by the presence of
these proteins in a complex, rather than as a result of anti-
body cross-reaction. Here, we have identified a further
member of the complex as the Xenopus homologue of
the S. pombe Cdc21 protein (Fig. 2). Our observation that
a complex of MCM proteins is present in Xenopus eggs
has been corroborated and has been observed in a range
of other cells [21,22,29,32], although in some cases
two discrete subcomplexes have been observed. Figure 1
illustrates the degree of sequence conservation between
members of this complex, even across species barriers.
The MCM complex is essential for the initiation of DNA
replication in Xenopus egg extracts [20-22]. DNA replica-
tion in extracts is known to occur at discrete replication
foci [30,33-36]. The MCM complex might therefore be
expected to concentrate at replication foci at some point
in the replication cycle. However, Figure 3 shows that
MCM3 is not preferentially localized at sites of DNA
replication; instead, it is almost uniformly distributed on
the chromatin and erased from the sites of replication.
Behaviour of MCM proteins during the cell cycle
MCM proteins were discovered in S. cerevisiae and named
because of their involvement in mini-chromosome main-
tenance [6]. Their involvement in DNA replication [7]
and their exclusion from the nucleus until anaphase of
mitosis [15,17] suggested that they might be good candi-
dates for the hypothetical licensing factor proposed by
Blow and Laskey [2]. However, although there is evidence
that they are required for replication licensing [20-22], the
MCM proteins of higher eukaryotes appear to be nuclear
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throughout the cell cycle ([10,11,18,19]; T. Krude, C.
Musahl, R.A.L. and R. Knippers, personal communi-
cation). Instead of their presence or absence in the nucleus
varying through the cell cycle, their binding to chromatin
varies ([18,23]; T. Krude, C. Musahl, R.A.L. and R.
Knippers, personal communication). As replication pro-
ceeds, MCM3 is displaced from chromatin, but in vivo it
remains in the nucleus in a soluble, detergent-extractable
form (Fig. 4; [18,20-23]; T. Krude, C. Musahl, R.A.L.
and R. Knippers, personal communication).
Figure 5 shows that DNA replication is required for the
displacement of XMCM3 from chromatin. It also shows
that 76 % of the chromatin-bound XMCM3 immuno-
fluorescence is lost when only 10 % of the chromatin has
replicated. These results should be interpreted with cau-
tion, as we cannot rule out the possibility that the early
loss in fluorescence is a side effect of stalling replication
forks following prolonged incubation in aphidicolin.
This possibility seems unlikely, however, because the sub-
sequent removal of aphidicolin has no effect on the pro-
gression of replication forks [37]. The results shown in
Figure 5 support the possibility that XMCM3 displace-
ment is triggered by an early event in replication, possibly
initiation itself, but that release is delayed. Once displace-
ment has been triggered by an early replication event,
then the delay before release is independent of DNA
replication (Fig. 5). It will be interesting to see whether
the delay corresponds to a chromatin maturation event or
is mediated by the phosphorylation of MCM proteins
when they are displaced [18,23]:
The nuclear membrane restricts binding of XMCM3 to
chromatin, but not its entry into the nucleus
Permeabilizing the nuclear membrane allows replicated
nuclei to replicate their DNA again [2,3,31]. We have
shown previously that XMCM3 can cross the intact
membrane of an unreplicated sperm nucleus. Figure 6
shows that this is also true of a replicated HeLa G2-phase
nucleus. Therefore, the critical effect of permeabilizing a
G2-phase nucleus cannot be to allow entry of XMCM3.
Kubota et al. [22] showed that a bacterially expressed
XMCM3 fusion protein was unable to cross the nuclear
membrane. The most interesting explanation for this dif-
ference between the fusion protein and the endogenous
complex is that another MCM protein in the complex
contains a signal that transports the whole complex into
the nucleus. This possibility remains to be tested.
Although nuclear membrane permeabilization is not re-
quired for entry of XMCM3, it is required for XMCM3
to bind to chromatin (Figs 6,7). The ability of G2-phase
nuclei to reinitiate replication coincides with the binding
of XMCM3 to chromatin and does not occur when the
XMCM complex is immunodepleted (Figs 6,7).
A two-stage model of replication licensing
Figure 7 shows that a second cytosolic loading factor is
required for XMCM3 to bind to chromatin, and that this
Fig 8. A two-stage model for 'replication licensing' [2,41]. The
MCM protein complex, acting as the 'licence', can cross the
nuclear envelope throughout interphase. However, cytosolic
'loading factor' is excluded from the chromatin by an intact
nuclear envelope during interphase. The loading factor can enter
the nucleus only during mitosis, allowing MCM3 to bind chro-
matin at any point between mitosis and S phase. Loading factor
must be inactivated before or during initiation of DNA replica-
tion to explain why MCM3 is unable to bind replicated chro-
matin during S or G2 phases (Figs 6,7; [18,20-22]). The
persistence of an intact nuclear envelope until mitosis prevents
further binding of MCM3 until nuclear envelope breakdown,
thereby limiting DNA replication to once per cell cycle.
second factor is excluded by the nuclear membrane. A
prime candidate for the loading factor is fraction RLF-B,
which is also required for licensing [21]. Therefore, as
summarized in Figure 8, licensing can be resolved into
two separate steps and only the first requires a permeable
nuclear membrane. The two stages of licensing can be
likened to the sequential-need for a ticket and a boarding
pass to board an aircraft. The loading factor (or 'ticket') is
required in order to obtain the MCM complex (or 'board-
ing pass'), which then allows a single round of replication
(or 'flight') and is surrendered on use. It is possible to
debate semantically which of these two factors should be
called the 'licensing factor', but this ambiguity could cause
confusion. We therefore suggest that the name 'licensing
factor' should be discontinued, to avoid confusion, but
that the term 'replication licensing' should continue.
Materials and methods
Preparation of extract and nuclei
Low- and high-speed Xenopus egg extracts were prepared
essentially as reported [38,39]. The preparation of demem-
branated sperm nuclei has been described previously [38].
Synchronous HeLa G2-phase cells were prepared essentially as
in [31]. Intact nuclei were prepared as described, with the
exception that all incubations were carried out in HE buffer
(50 mM Hepes-KOH, pH 7.4; 50 mM KCI; 5 mM MgC1 2;
1 mM EGTA; 1 mM DTT; I pg ml- aprotinin, pepstatin,
leupeptin and chymostatin).
Nuclear membrane permeabilization
Streptolysin O-prepared HeLa G2-phase nuclei [31] and
replicated Xenopus sperm nuclei were incubated with
1001 gml-' lysolecithin (Sigma Immunochemicals) in HE
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buffer at a concentration of approximately 5 x 105 nuclei per
ml, for 10 min at 23 °C with occasional gentle mixing. Reac-
tions were stopped by the addition of 3 % nuclease-free BSA
(Sigma Chemicals). Nuclei were gendtly pelleted at 600 x g for
10 min, resuspended in HE buffer and overlayed onto a step of
30 % sucrose in HE buffer. Nuclei were pelleted and resus-
pended in a small volume of 30 % sucrose in HE buffer to
approximately 1 x 104 nuclei per J.
Replication reactions
Aliquots of frozen extract were thawed at 23 C and
supplemented immediately with an ATP-regenerating system
(10 mM creatine phosphate (Boehringer Mannheim);
20 Jtg ml- l creatine phosphokinase (Boehringer Mannheim);
1 mM ATP (Sigma); 1 mM MgC12; mM GTP (Boehringer
Mannheim); 5 mM Hepes, pH 7.5; 1 mM DTT). Extracts
were depleted using anti-XMCM3 antibodies, as described
previously [20]. Mock depletions were carried out using pro-
tein A-Sepharose-conjugated rabbit anti-rat IgG. Extracts were
then supplemented with DNA (3-5 ng sperm or 500 HeLa
G2-phase nuclei per pl of extract in a final volume of extract of
15-20 pI), 20 J.M biotin-16-dUTP (Boehringer Mannheim),
2 LCi at-[32 P]dATP (3000 Ci mM-1; Dupont NEN) per 10 pl
extract, and 0.4 mM BrdUTP.
Incubations in XMCM3-depleted extract were transferred to
mock-depleted extract by dilution in a 10-fold excess of mock-
depleted extract (Fig. 7). Nuclear membrane integrity was
monitored by supplementing incubations with fluorescein-
labelled nucleoplasmin core fragment [40] immediately before
transfer to mock-depleted extract. Nuclei were checked for
integrity following transfer.
TCA precipitation and density substitution
For measurement of ct-[ 3 2P]dATP incorporation into DNA
(Fig. 5a), duplicate 1 pl samples were dried onto Whatman
GF/C filter papers, precipitated with TCA, washed with
ethanol, dried, and counted in Optiphase scintillation fluid
(Wallace). Quantification of DNA replication was based on the
assumption that the dATP pool size in the extract is 50 JtM [41].
For density substitution, reactions were stopped by the
addition of 80 1 buffer containing 0.5 % SDS, 20 mM
Hepes-KOH (pH 7.4) and 20 mM EDTA. After incubation
for h at 37 °C with 1 mg ml- l proteinase K (Sigma), reac-
tions were extracted three times with phenol/chloroform.
DNA was then fractionated on caesium chloride gradients, as
described previously [38].
Microscopy
Samples were diluted in 500 p1 extract buffer (EB, [41]) or
500 pl detergent-wash buffer (EB supplemented with 0.1 %
Triton X-100; Sigma). A further 500 p1 of 10 % formalin
solution was added and samples were incubated at room
temperature for 10 min with gentle mixing. Nuclei were spun
onto coverslips [33] and stained for biotin-dUTP, RPA and
XMCM3 using the procedure described previously [42].
XMCM3 immunofluorescence was quantified by comparing
fluorescence intensities collected at identical settings on the
scanning laser confocal microscope (BioRad MRC600). Data
representing total pixel intensities across the equatorial plane of
each nucleus were estimated with NIH Image software.
Immunoprecipitations
Immunoprecipitations were carried out as described previously
[20]. Protein A-Sepharose beads cross-linked with rabbit anti-
XMCM3 antibodies were incubated for 1 h with Xenopus egg
extract. Beads were washed ten times in a 50-fold volume of
EB over a period of 1 h at 4 °C. Beads were recovered by cen-
trifugation, and samples were subjected to 5 % SDS-PAGE.
Gels were either Coomassie stained or immunoblotted.
Immunoreactive proteins were detected by ECL (Amersham).
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